Molecular targeted therapies: Ready for “prime time” in biliary tract cancer
Author:
Funder
Christie Charity
Publisher
Elsevier BV
Subject
Hepatology
Reference186 articles.
1. Incidence of cholangiocarcinoma in the USA from 2001 to 2015: a US cancer statistics analysis of 50 states;Patel;Cureus,2019
2. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States;Patel;Hepatology,2001
3. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998;Taylor-Robinson;Gut,2001
4. Recent advances in the management of cholangiocarcinomas;Vauthey;Semin Liver Dis,1994
5. Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions;Anderson;Cancer Treat Rev,2009
Cited by 256 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthetic routes and clinical application of new drugs approved by EMA during 2023;European Journal of Medicinal Chemistry;2024-11
2. The advancements and prospective developments in anti-tumor targeted therapy;Neoplasia;2024-10
3. Targeted Therapy with Polymeric Nanoparticles in PBRM1-Mutant Biliary Tract Cancers: Harnessing DNA Damage Repair Mechanisms;Critical Reviews in Oncology/Hematology;2024-09
4. Discovery of Aloperine as a Potential Antineoplastic Agent for Cholangiocarcinoma Harboring Mutant IDH1;International Journal of Molecular Sciences;2024-08-25
5. Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches;Cancers;2024-08-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3